Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Value Type description Rank Gene Interaction Map Network Comparison Type Filtered green red network_comparison
Results: HTML CSV LaTeX
Showing element 432 to 481 of 3228 in total
Value Type: Measured
Interaction Map: High confidence
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
branched-chain amino acid aminotransferase, cytosolic (ec 2.6.1.42) (bcat(c)) (eca39 protein). [source:swissprot;acc:p54687]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1213\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6396.53\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5890.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08588\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
branched-chain amino acid aminotransferase, mitochondrial precursor (ec 2.6.1.42) (bcat(m)) (placental protein 18) (pp18). [source:swissprot;acc:o15382]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1215\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6397.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5892.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08575\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brca1 associated protein. [source:refseq;acc:nm\_006768]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3161\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brca1-associated ring domain protein 1 (bard-1). [source:swissprot;acc:q99728]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1939\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6015.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5669.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.061\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brca2 and cdkn1a-interacting protein isoform bccipalpha; brca2 and cdkn1a-interacting protein; cdk inhibitor p21 binding protein; bccipalpha; bccipbeta; tok-1alpha; tok-1beta. [source:refseq;acc:nm\_016567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2116\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3482.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3672.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0546\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
breast cancer antiestrogen resistance 3. [source:refseq;acc:nm\_003567]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
173\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5940.64\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4579.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29727\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
breast cancer type 1 susceptibility protein. [source:swissprot;acc:p38398]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2442\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5637.88\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5454.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
breast carcinoma amplified sequence 2; spliceosome associated protein, amplified in breast cancer. [source:refseq;acc:nm\_005872]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
418\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6350.19\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5493.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15603\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 1 (brefeldin a-inhibited gep 1) (p200 arf-gep1) (p200 arf guanine nucleotide exchange factor). [source:swissprot;acc:q9y6d6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1425\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6063.61\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5628.53\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.0773\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
brefeldin a-inhibited guanine nucleotide-exchange protein 2 (brefeldin a-inhibited gep 2). [source:swissprot;acc:q9y6d5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1423\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
brg1-binding protein eld/osa1; eld (eyelid)/osa protein. [source:refseq;acc:nm\_020732]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
443\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7192.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6252.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain and phd finger-containing protein 3 (fragment). [source:swissprot;acc:q9uld4]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3149\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain containing 7; bromodomain protein; bromodomain-containing 7. [source:refseq;acc:nm\_013263]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1925\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7711.29\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7260.23\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06213\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain-containing protein 1 (br140-like protein). [source:swissprot;acc:o95696]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3139\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain-containing protein 2 (ring3 protein) (o27.1.1). [source:swissprot;acc:p25440]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1892\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.52\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06334\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain-containing protein 3 (ring3-like protein). [source:swissprot;acc:q15059]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1891\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5782.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.18\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bromodomain-containing protein 4 (hunk1 protein). [source:swissprot;acc:o60885]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1888\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5783.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5438.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06335\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bs4 protein (ny-ren-18 antigen). [source:swissprot;acc:q9y5a7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3214\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bullous pemphigoid antigen 1 isoforms 1/2/3/4/5/8 (230 kda bullous pemphigoid antigen) (bpa) (hemidesmosomal plaque protein) (dystonia musculorum protein) (fragment). [source:swissprot;acc:q03001]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2664\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4576.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4608.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00702\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bup protein. [source:refseq;acc:nm\_012071]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2911\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
bystin. [source:swissprot;acc:q13895]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
950\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4697.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4280.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09718\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-1-tetrahydrofolate synthase, cytoplasmic (c1-thf synthase) [includes: methylenetetrahydrofolate dehydrogenase (ec 1.5.1.5); methenyltetrahydrofolate cyclohydrolase (ec 3.5.4.9); formyltetrahydrofolate synthetase (ec 6.3.4.3)]. [source:swissprot;acc:p11586]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2102\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5127.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4860.34\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05493\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-jun-amino-terminal kinase interacting protein 3 (jnk-interacting protein 3) (jip-3) (jnk map kinase scaffold protein 3) (mitogen- activated protein kinase 8-interacting protein 3). [source:swissprot;acc:q9upt6]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1962\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6297.78\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5941.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-terminal binding protein 1 (ctbp1). [source:swissprot;acc:q13363]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1638\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9248.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9895.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07002\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-terminal binding protein 2 (ctbp2). [source:swissprot;acc:p56545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1630\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
9253.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9903.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07018\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c-type lectin superfamily member 1 precursor (cartilage-derived c-type lectin). [source:swissprot;acc:o75596]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
488\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12447\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10872.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14483\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c1 domain-containing phosphatase and tensin-like protein isoform 2; putative protein tyrosine phosphatase; c1 domain-containing phosphatase and tensin-like protein; tensin 2. [source:refseq;acc:nm\_015319]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1528\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6301.24\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5869.97\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
707\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5944.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5317.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11781\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c316g12.2 (novel protein similar to predicted yeast, worm and archae- bacterial proteins) (similar to und313) (s. cervisiae) (hypothetical protein). [source:sptrembl;acc:q9ujk0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2120\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7329\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6951.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05434\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c367g8.3 (novel protein similar to rpl23a (60s ribosomal protein l23a)) (60s ribosomal protein l23a like). [source:sptrembl;acc:q9br02]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2174\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
3463.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3641.45\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05152\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
c439a6.1 (novel protein similar to heparan sulfate (glucosamine) 3-o- sulfotransferases) (fragment). [source:sptrembl;acc:q96qi5]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2421\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7088.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7355.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0376\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ca2+-dependent endoplasmic reticulum nucleoside diphosphatase; apyrase; soluble calcium-activated nucleotidase scan-1. [source:refseq;acc:nm\_138793]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
874\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
10941.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9921.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.10278\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
caax prenyl protease 1 homolog (ec 3.4.24.-) (prenyl protein-specific endoprotease 1) (farnesylated-proteins converting enzyme 1) (face-1) (zinc metalloproteinase ste24 homolog). [source:swissprot;acc:o75844]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
941\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5455.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4970.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09761\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cab2. [source:refseq;acc:nm\_033419]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2618\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5683\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5599.85\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.01485\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cad protein [includes: glutamine-dependent carbamoyl-phosphate synthase (ec 6.3.5.5); aspartate carbamoyltransferase (ec 2.1.3.2); dihydroorotase (ec 3.5.2.3)]. [source:swissprot;acc:p27708]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1217\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6536.45\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6021.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08557\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
cadherin-related tumor suppressor homolog precursor (fat protein homolog). [source:swissprot;acc:q14517]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1723\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5830.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5458.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 1 (down syndrome critical region protein 1) (myocyte- enriched calcineurin interacting protein 1) (mcip1) (adapt78). [source:swissprot;acc:p53805]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1356\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6103.57\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5657.71\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07881\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 2 (thyroid hormone-responsive protein zaki-4) (down syndrome candidate region 1-like 1) (myocyte-enriched calcineurin interacting protein 2) (mcip2). [source:swissprot;acc:q14206]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1360\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6103.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5657.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07879\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcipressin 3 (down syndrome candidate region 1-like protein 2) (myocyte-enriched calcineurin interacting protein 3) (mcip3). [source:swissprot;acc:q9uka8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1361\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar1 (solute carrier family 25, member 12). [source:swissprot;acc:o75746]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1913\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7287.27\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6858.84\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.06246\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-binding mitochondrial carrier protein aralar2 (solute carrier family 25, member 13) (citrin). [source:swissprot;acc:q9ujs0]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1916\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-dependent protease, small subunit (calpain regulatory subunit) (calcium-activated neutral proteinase) (canp). [source:swissprot;acc:p04632]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
440\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7192.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6251.91\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.15038\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium-transporting atpase type 2c, member 1 (ec 3.6.3.8) (atpase 2c1) (atp-dependent ca(2+) pump pmr1) (hussy-28). [source:swissprot;acc:p98194]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
606\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6955.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6148.94\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.13121\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii alpha chain (ec 2.7.1.123) (cam-kinase ii alpha chain) (cam kinase ii alpha subunit) (camk-ii alpha subunit). [source:swissprot;acc:q9uqm7]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1385\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.07829\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii beta chain (ec 2.7.1.123) (cam-kinase ii beta chain) (cam kinase ii beta subunit) (camk-ii beta subunit). [source:swissprot;acc:q13554]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1386\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6555.41\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6079.46\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii delta chain (ec 2.7.1.123) (cam-kinase ii delta chain) (cam kinase ii delta subunit) (camk-ii delta subunit). [source:swissprot;acc:q13557]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1376\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
calcium/calmodulin-dependent protein kinase type ii gamma chain (ec 2.7.1.123) (cam-kinase ii gamma chain) (cam kinase ii gamma subunit) (camk-ii gamma subunit) (fragment). [source:swissprot;acc:q13555]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1375\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6555.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6079.45\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calcyphosine. [source:swissprot;acc:q13938]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6088.47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17334\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calmegin precursor. [source:swissprot;acc:o14967]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1473\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6355.08\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5910.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0753\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
calmodulin. [source:swissprot;acc:p02593]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2928\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/